Use of des-aspartate-angiotensin i in inflammation-related pathologies and diseases
OwnerMeng Kwoon Siminventor
Life of this patent
Estimating the term…
Abstract
The present disclosure generally relates to the use of des-aspartate-angiotensin I and/or its derivatives in medicine. In particular, the present invention relates to the use of des-aspartate-angiotensin I and/or its derivatives for the treatment and/or prophylaxis of inflammatory diseases or pathologies, for inducing anti-inflammatory actions and/or reducing inflammation, and/or for treatment of inflammation-related conditions.
Claims21
A method for the treatment and/or prevention of inflammatory diseases and pathologies or diseases that are inflammatory in nature in a subject in need of such treatment and/or prevention comprising administering to the subject an effective amount of des-aspartate-angiotensin I or its derivatives.
A pharmaceutical composition comprising an effective amount of des-aspartate-angiotensin I or its derivatives, and at least one pharmaceutically acceptable carrier, excipient, diluent and/or adjuvant.
20-55. (canceled)
A kit comprising des-aspartate-angiotensin I or its derivatives, wherein the kit is for the treatment and/or prevention of inflammatory diseases and pathologies or diseases that are inflammatory in nature in a subject in need of such treatment and/or prevention.
Dependencies are inferred from the claim text.